Hurd,Yasmin, Ph.D. Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2010
NCT01311778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hurd,Yasmin, Ph.D.